GlassScriptPhysician profile
Mica Y Bergman
NPI 1912268996
$2,977.36
in general payments reported to CMS, 2019-2025
16 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Ophthalmic Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $299).
See the full distribution for Ophthalmic Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $804 · 2020: $449 · 2021: $330 · 2022: $658 · 2023: $121 · 2024: $215 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $735.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $553.87 | 2020-2023 | Tepezza |
| Alcon Vision LLC | $422.41 | 2019-2025 | Centurion |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $361.03 | 2019-2020 | |
| New World Medical,INC. | $297.51 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $292.99 | 2022-2025 | |
| Glaukos Corporation | $131.99 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $123.35 | 2022 | |
| Sight Sciences, INC. | $122.76 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $111.58 | 2019 | |
| Dompe US, INC. | $111.04 | 2024 | Oxervate |
| Bausch & Lomb Americas INC. | $104.17 | 2024 | Miebo, Xiidra |
| Aerie Pharmaceuticals, INC. | $102.23 | 2019 | |
| Neurotech Pharmaceuticals, INC. | $100.51 | 2025 | |
| Allergan, INC. | $92.83 | 2021 | |
| Abbvie INC. | $29.69 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mica Bergman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.